Why the study?
Does carvedilol infusion alter hemodynamics and sympathetic nervous system activity in rats with heart failure compared to normal rats?
Does carvedilol infusion alter hemodynamics and sympathetic nervous system activity in rats with heart failure compared to normal rats?
In a rat model of heart failure, carvedilol infusion demonstrates that presynaptic sympathetic nervous system activity is increased and receptor sensitivity is decreased.
Answers are grounded in this paper and cite their sources.
Should not guide human therapy; leaves open carvedilol's sympathetic effects in heart failure models.
We investigated the contribution of the sympathetic nervous system (SNS) in maintaining the blood pressure and in regulating the cardiac function during and after carvedilol administration in rats with heart failure (group F). Left ventricular end-diastolic pressure, percent functional shortening, and rates of intraventricular pressure rise were significantly changed by carvedilol infusion as compared with the basal values in group N (normal rats), but not in group F. The left ventricular end-diastolic pressure was elevated, corresponding to the enhancement of the plasma norepinephrine (NE) concentration caused by carvedilol infusion, in group N. The enhancement of the plasma NE concentration induced by carvedilol administration in group F was higher than that in group N. The value for the maximal hypertensive effect of NE intravenous infusion (Emax) was decreased, and the plasma NE concentration at half-maximal effect (EC50) was increased in group F as compared with the values in group N. These results indicate that the SNS (presynaptic) activity is increased and that the SNS receptor sensitivity in the cardiovascular regulation system is decreased in heart failure.
No takes yet. Share an insight, caveat, or question.
Abe et al. (2004) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: